Search - tctmd.com

Displaying 501 - 520 of 1039

Sort: Relevancy | Date

Presentation TCT 2015

Insights From BioImage: Vulnerable Plaque Is a Systemic Disease

Presenter: Gregg W. Stone, Renu Virmani, Roxana Mehran

October 12, 2015

Presentation TCT 2015

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

Presenter: Shigeru Saito, Gregg W. Stone, Ron Waksman, Shigeru Saito

October 12, 2015

Presentation TCT 2015

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Run-Lin Gao, Gregg W. Stone, Ron Waksman, Run-Lin Gao

October 12, 2015

Presentation TCT 2015

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Gregg W. Stone, Ron Waksman, Dean J. Kereiakes

October 12, 2015

Presentation TCT 2015

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies Focused Commentary

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, Roxana Mehran

October 12, 2015

Presentation TCT 2015

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, Marco Valgimigli

October 12, 2015

Presentation TCT 2015

DAPT Duration After DES: Does 1 Size Fit All? Focused Commentary

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, John A. Bittl

October 12, 2015

Presentation TCT 2015

DAPT Duration After DES: Does 1 Size Fit All?

Presenter: Robert A. Harrington, Gregg W. Stone, David J. Cohen, John A. Bittl

October 12, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Industry News

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

October 12, 2015

News Conference News TCT 2015

Absorb BVS Matches Xience V in Chinese Patients

Todd Neale

October 12, 2015

Presentation TCT 2015

A Complex NonLeft Main Bifurcation: Function vs Morphology

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone, Jung-Min Ahn

October 11, 2015

Presentation TCT 2015

A Complex Left Main Bifurcation

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone, Marie-Claude Morice

October 11, 2015

Presentation TCT 2015

We Need More Data: STABLE and PREVENT

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

I Want to Treat Vulnerable Plaques: Not Today but Tomorrow (From PROSPECT to PROSPECT ABSORB)

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Functionally Insignificant Vulnerable Plaque: Just Defer It!

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone, Nico H.J. Pijls

October 11, 2015

Presentation TCT 2015

How to Define Vulnerable Plaque? What Does It Mean?

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone, Akiko Maehara

October 11, 2015

Presentation TCT 2015

NonLeft Main Bifurcation PCI: Insight From CROSS, PERFECT, and DK CRUSH Trials

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone, Young-Hak Kim

October 11, 2015

Presentation TCT 2015

Update of PCI vs CABG for Left Main PCI (Beyond SYNTAX, PRECOMBAT, BEST, and Meta-analysis 2015): What's Different From 3-Vessel Disease?

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Use of FFR and IVUS for Long and Tandem Lesions PCI

Presenter: Gary S. Mintz, Seung-Jung Park, Gregg W. Stone, Jung-Min Ahn

October 11, 2015

Advertisement

Insights From BioImage: Vulnerable Plaque Is a Systemic Disease

A Prospective Randomized Trial of Transradial vs Transfemoral Access in Patients Undergoing Coronary Angiography and Intervention

ABSORB China: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

ABSORB III: A Prospective Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold vs an Everolimus-Eluting Metallic Stent in Patients With Coronary Artery Disease

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies Focused Commentary

Periprocedural Antiplatelet Therapy: Agent(s) of Choice, Oral vs IV, and Loading Strategies

DAPT Duration After DES: Does 1 Size Fit All? Focused Commentary

DAPT Duration After DES: Does 1 Size Fit All?

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease

Absorb BVS Matches Xience V in Chinese Patients

A Complex NonLeft Main Bifurcation: Function vs Morphology

A Complex Left Main Bifurcation

We Need More Data: STABLE and PREVENT

I Want to Treat Vulnerable Plaques: Not Today but Tomorrow (From PROSPECT to PROSPECT ABSORB)

Functionally Insignificant Vulnerable Plaque: Just Defer It!

How to Define Vulnerable Plaque? What Does It Mean?

NonLeft Main Bifurcation PCI: Insight From CROSS, PERFECT, and DK CRUSH Trials

Update of PCI vs CABG for Left Main PCI (Beyond SYNTAX, PRECOMBAT, BEST, and Meta-analysis 2015): What's Different From 3-Vessel Disease?

Use of FFR and IVUS for Long and Tandem Lesions PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content